Experts Skeptical of Controversial Deep Brain Stimulation for Autism-Related Self-Harm

Got story updates? Submit your updates here. ›

A new study published in Science Advances explores the use of deep brain stimulation (DBS) to regulate self-injurious behavior in children with autism by targeting the nucleus accumbens. While the researchers report promising results, leading experts express skepticism about the study design, lack of control groups, and the broader feasibility of implementing DBS as a treatment. The experts argue that without stronger trial designs to separate stimulation effects from other factors, the scientific community risks talking itself into clinical momentum before the evidence is ready.

Why it matters

The debate around DBS for autism-related self-harm highlights the tension between the emotional promise of a 'brain stimulation' solution and the scientific realities of translating a neurosurgical technique into a reliable treatment. Experts caution that small sample sizes and lack of control groups make it difficult to determine if the reported improvements are truly due to the DBS intervention or could be explained by other factors like natural fluctuations, placebo effects, or changes in caregiver support. They argue the bar for evidence should be higher given the invasive nature and practical barriers of DBS.

The details

The study focuses on electrical stimulation of corticostriatal circuits involving the nucleus accumbens, a brain region linked to reward and motivation systems. Researchers report benefits in both mouse models and a small group of children with autism. However, leading experts like Prof Geoff Bird from Oxford express skepticism, primarily due to the lack of a proper comparison group in the child data. Without a control group, it's difficult to separate stimulation effects from other factors like time-related improvements, caregiver changes, or placebo/context effects. Experts also note practical barriers to widespread DBS implementation, such as the limited number of hospitals capable of performing the surgery and the infection risks associated with the invasive procedure.

• The study was published in Science Advances in April 2026.

What’s next

The experts suggest that the next steps should prioritize trials with appropriate control conditions, transparent outcome definitions, and longer follow-up to assess durability and safety. They also recommend more integration between invasive and non-invasive approaches, starting with mechanistic validation, then moving to safety-focused trials, and finally to controlled efficacy trials, ideally alongside non-invasive comparators.